by Stephanie Li for DealStreetAsia

“Biotech firm Angitia Biopharmaceuticals has snagged $46 million in a Series B extension round led by Morningside Ventures, according to a company announcement on October 19.

Morningside, founded in 1986 by Hong Kong property tycoon Ronnie Chan Chi-chung’s family, makes venture capital and private equity investments across North America, Europe, and Asia Pacific….”

Continue reading at the original source, linked here.